As the population ages, the number of operations performed on bone is expected to increase. Diseases such as arthritis, tumours, and trauma can lead to defects in the skeleton requiring an operation to replace or restore the lost bone. Surgeons can use autografts, allografts, and/or bone graft substitutes to restore areas of bone loss. Surgical implants are also used in addition or in isolation to replace the diseased bone. This review considers the application of available bone grafts in different clinical settings. It also discusses recently introduced bioactive biomaterials and highlights the clinical difficulties and technological deficiencies that exist in our current surgical practice.
GrayH.Anatomy of the human body20001396Lea & Febiger, Philadelphia, Pennsylvania
2.
StevensM. M.GeorgeJ. H.Exploring and engineering the cell surface interface. Science2005310, (5751), 1135–1138
3.
JagerM. Z. C.ZangerK.KrauspeR.Significance of nano- and microtopography for cell-surface interactions in orthopaedic implants. J. Biomed. Biotech.20078, 1–19
4.
GastonM. S.SimpsonA. H. R. W.Inhibition of fracture healing. J. Bone Joint Surg. Br.200789B, 1553–1560
5.
McKibbinB.The biology of fracture healing in long bones. J. Bone Joint Surg. Br.197860B, 150–162
6.
BrightonC. T.HuntR. M.Early histologic and ultrastructural changes in microvessels of periosteal callus. J. Orthop. Trauma199711, (4), 244–253
7.
JagodzinskiM.KrettekC.Effect of mechanical stability on fracture healing - an update. Injury200738, (S1), S3–S10
8.
SmithW. R.ZiranB. H.AnglenJ. O.StahelP. F.Locking plates: Tips and tricks. J. Bone Joint Surg. Am.200789A, 2298–2307
9.
GiannoudisP. V.EinhornT. A.MarshD.Fracture healing: The diamond concept. Injury, Int. J. Care Injured200738, (S4), S3–S6
10.
MegasP.Classification of non-union. Injury200536, (S4), S30–S37
11.
HollingerJ. O.WinnS.BonadioJ.Options for tissue engineering to address challenges of the ageing skeleton. Tissue Engng20006, (4), 341–350
12.
DicksonG. B. F.MarshD.Harkin-JonesE.LittleU.McCaigueM.Orthopaedic tissue engineering and bone regeneration. Technol. Health Care200715, 57–67
13.
ReidR. L.Hernia through an iliac bone graft donor site. A case report. J. Bone Joint Surg. Am.196850, 757–760
14.
PaleyD.HerzenbergJ. E.ParemainG.BhaveA.Femoral lengthening over an intramedullary nail. A matched-case comparison with Ilizarov femoral lengthening. J. Bone Joint Surg. Am.199779, 1464–1480
15.
GuichetJ. M.DeromedisB.DonnanL. T.PerettiG.LascombesP.BadoF.Gradual femoral lengthening with the Albizzia intramedullary nail. J. Bone Joint Surg. Am.200385, 838–848
16.
ManiadakisG.GrayA.The economic burden of back pain in the U.K. Pain200084, (1), 95–103
17.
The Health and Safety Executive. Back pain statistics,2006, available from http://www.hse.gov.uk/ (access date 15 October 2009)
18.
HsuW. K.WangJ. C.The use of bone morphogenetic protein in spine fusion. Spine J.20088, 419–425
Board of the Norwegian Arthroplasty Register and the Norwegian Hip Fracture Register., Norwegian arthroplasty register annual report 2007, available at http://www.haukeland.no/nrl/eng/default.htm (access date 15 October 2009)
GarellickG.RogmarkC.HerbertsP., Swedish national hip arthroplasty register annual report 2007, available at http://www.jru.orthop.gu.se/ (access date 15 October 2009)
CharnleyJ.Total hip replacement by low-friction arthroplasty. Clin. Orthop. Relat. Res.197072, 7–21
29.
BerryD. J.HarmsenW. S.CabanelaM. E.Twenty-five year survivorship of two thousand consecutive primary Charnley total hip replacements: Factors affecting survivorship of acetabular and femoral components. J. Bone Joint Surg. Am.200284, 171–177
30.
HarrisW. H.SchillerA. L.SchollerJ. M.Extensive localized bone resorption in the femur following total hip replacement. J. Bone Joint Surg. Am.197658, 612–618
31.
HoltG.MurnaghanC.ReillyJ.The biology of aseptic osteolysis. Clin. Orthop. Relat. Res.2007460, 240–252
LieS. A.HavelinH. I.FurnesO. N.Failure rates for 4762 revision total hip arthroplasties in the Norweigian Arthroplasty Register. J. Bone Joint Surg. Br.200486, 504–509
35.
NishidaJ.ShimamuraT.Methods of reconstruction for bone defect after tumor excision: A review of alternatives. Med. Sci. Monit.200814, (8), RA107–113
36.
KhanS. N.CammisaF. P.SandhuH. S.The biology of bone grafting. J. Am. Acad. Orthop. Surg.200513, (1), 77–86
37.
CoventryM. B.TapperE. M.Pelvic instability: A consequence of removing iliac bone for grafting. J. Bone Joint Surg. Am.197266, 82–101
38.
ReidR. L.Hernia through an iliac bone graft donor site. A case report. J. Bone Joint Surg. Am.196850, 757–760
39.
YoungerE.Morbidity at bone graft donor sites. J. Orthop. Trauma19893, 192–195
40.
HsuW. W. R.WoodM. B.SimF. H.Free vascularised fibular grafting for reconstruction after tumour resection. J. Bone Joint Surg. Br.199779, (1), 36–42
41.
LeeK. S.HanS. B.BaekJ. R.Free vascularized osteocutaneous fibular graft to the tibia in 51 consecutive cases. J. Reconstr. Microsurg.200420, (4), 277–284
42.
GebertC.HillmanA.SchwappachA.Free vascularised fibular grafting for reconstruction after tumor resection in the upper extremity. J. Surg. Oncol.200694, 111–127
43.
de BoerH.WoodM. B.Bone changes in vascularised fibular graft. J. Bone Joint Arthropl.198971, (3), 374–378
44.
ChangT. I.ZhuS. X.WangZ. C.Principles, techniques, and applications in microsurgery1986, ch.18 World Scientific Publishing, Singapore
Norman-TaylorF. H.VillarR. N.Bone allograft: A cause for concern?J. Bone Joint Surg. Br.199779B, (2), 178–180
47.
WardW. G.GautreauxM. D.LippertD. C.HLA sensitization and allograft bone graft incorporation. Clin. Orthop. Relat. Res.2008466, (8), 1837–1848
48.
BoyceT.EdwardsJ.ScarboroughN.The influence of processing on safety and performance. Orthop. Clin. North. Am.19994, 571–581
49.
DickH. M.StrauchR. J.Infection of massive bone allografts. Clin. Orthop. Rel. Res.1994306, 46–53
50.
ChapmanP. G.VillarR. N.The bacteriology of bone allografts. J. Bone Joint Surg. Br.199274, 398–399
51.
GaleaG.KopmanD.GrahamB. J. M.Supply and demand of bone allograft for revision hip surgery in Scotland. J. Bone Joint Surg. Br.199880B, 595–599
52.
YatesP.ThomsonJ.GaleaG.Processing of whole femoral head allografts: Validation methodology for the reliable removal of nucleated cells, lipid and soluble proteins using a multi-step washing procedure. Cell Tissue Bank20056, (4), 277–285
53.
SchreursB. W.KeurentjesJ. C.GardeniersJ. W.Acetabular revision with impacted morsellised cancellous bone grafting and a cemented acetabular component: A 20- to 25-year follow-up. J. Bone Joint Surg. Br.200991, (9), 1148–1153
54.
RobinsonM. C.FernlundG.Dominic MeekR. M.Structural characteristics of impaction allografting for revision total hip arthroplasty. Clin. Biomech.200520, (8), 853–855
55.
MankinH. J.SpringfieldD. S.GebhardtM. C.Current status of allografting for bone tumors. Orthopaedics199215, 1147–1154
56.
ArangurenM. S. J.LeyesM.MoraG.Consolidation of massive bone allografts in limb-preserving operations for bone tumours. Int. Orthop.199519, 377–382
57.
WangJ. C.AlanyA.DaviesM.KanimL. E. A.CampbellP. A.DawsonE. G.LiebermanJ. R.A comparison of commercially available demineralised bone matrix for spinal fusion. Eur. Spine J.200716, 1233–1240
58.
BaeB. H.ZhaoL.ZhuD.KanimL. E.WangJ. C.DelamarterR. B.Variability across ten production lots of a single demineralized bone matrix product. J. Bone Joint Surg. Am.201092, 427–435
59.
SchwartzZ.SomersA.MellonigJ. T.CarnesD. L.Ability of commercial demineralized freeze-dried bone allograft to induce new bone formation is dependent on donor age but not gender. J. Periodontol.199869, 470–478
60.
TraianedesK.RussellJ. L.EdwardsJ. T.StubbsH. A.ShanahanI. R.KnaackD.Donor age and gender effects on osteoinductivity of demineralized bone matrix. J. Biomed. Mater. Res. B, Appl. Biomater.200470, 21–29
61.
BabisG. C.SakellariouV. I.O'ConnorM. I.HanssenA. D.SimF. H.Proximal femoral allograft-prosthesis composites in revision hip replacement: A 12-year follow-up study. J. Bone Joint Surg.Br.201092, (3), 349–355
62.
KhanS. N.TominE.LaneJ. M.Clinical applications of bone graft substitutes. Orthop. Clin. North Am.200031, 389–398
63.
BohnerM.Calcium orthophosphates in medicine: From ceramics to calcium phosphate cements. Injury200031, (S4), S37–S47
64.
LeGerosR. Z.LinS.RohanizadehR.Biphasic calcium phosphate bioceramics: Preparation, properties and applications. J. Mater. Sci., Mater. Med.200314, (3), 201–209
65.
LeGerosR. Z.Properties of osteoconductive biomaterials: Calcium phosphates. Clin. Orthop.2002395, 81–98
66.
DaiL. Y.JiangL. S.Single-level instrumented posterolateral fusion of lumbar spine with beta-tricalcium phosphate versus autograft: A prospective, randomized study with 3-year follow-up. Spine200833, (2, 1299–1304
67.
EpsteinN. E.Beta tricalcium phosphate: Observation of use in 100 posterolateral lumbar instrumented fusions. Spine J.20099, (8), 630–638
68.
OgoseA.HottaT.KawashimaH.Comparison of hydroxyapatite and beta tricalcium phosphate as bone substitutes after excision of bone tumors. J. Biomed. Mater. Res. B, Appl. Biomater.200572, (1), 94–101
FujibayashiS.ShikataJ.TanakaC.Lumbar posterolateral fusion with biphasic calcium phosphate ceramic. J. Spinal Disord.200114, 214–221
71.
Moro-BarreroL.Acebal-CortinaG.Suárez-SuárezM.Radiographic analysis of fusion mass using fresh autologous bone marrow with ceramic composites as an alternative to autologous bone graft. J. Spinal Disord. Tech.200720, (6), 409–415
72.
KasaiY.TakegamiK.UchidaA.Mixture ratios of local bone to artificial bone in lumbar posterolateral fusion. J. Spinal Disord. Tech.200316, 31–37
73.
FriedmannA.DardM.KleberB. M.Ridge augmentation and maxillary sinus grafting with a biphasic calcium phosphate: Histologic and histomorphometric observations. Clin. Oral Implants Res.200920, (7), 708–714
74.
BlomA. W.WyldeV.LiveseyC.Impaction bone grafting of the acetabulum at hip revision using a mix of bone chips and a biphasic porous ceramic bone graft substitute. Acta Orthop.200980, (2), 150–154
75.
WangC.DuanY.MarkovicB.Phenotypic expression of bone-related genes in osteoblasts grown on calcium phosphate ceramics with different phase compositions. Biomaterials200425, 2507–2514
76.
YaoF.LeGerosJ. P.LeGerosR. Z.Simultaneous incorporation of carbonate and fluoride in synthetic apatites: Effect on crystallographic and physico-chemical properties. Acta Biomater.20095, (6), 2169–2177
77.
WangX.YeJ.Variation of crystal structure of hydroxyapatite in calcium phosphate cement by the substitution of strontium ions. J. Mater. Sci., Mater. Med.200819, (3), 1183–1186
78.
HingK. A.RevellP. A.SmithN.Effect of silicon level on rate, quality and progression of bone healing within silicate-substituted porous hydroxyapatite scaffolds. Biomaterials200627, (29), 5014–5026
79.
WheelerD. L.JenisL. G.KovachM. E.Efficacy of silicated calcium phosphate graft in posterolateral lumbar fusion in sheep. Spine J.20077, (3), 308–317
AtilganS.YamanF.YilmazU.GörgünB.ÜnlüG.An experimental comparison of the effects of calcium sulphate particles and β-tricalcium phosphate/hydroxyapatite granules on osteogenesis in internal bone cavities. Biotechnol.20072, (21), 205–210
82.
ChenW. J.Tsung-TingT.ChenL. H.The fusion rate of calcium sulfate with local autograft bone compared with autologous iliac bone graft for instrumented short-segment spinal fusion. Spine200530, (20), 2293–2297
Di SilvioL.DalbyM. J.BonfieldW.Osteoblast behaviour on HA/PE composite surfaces with different HA volumes. Biomaterials200223, 101–107
85.
AthanasiouK. A.NiederauerG. G.AgrawalC. M.Sterilization, toxicity, biocompatibility and clinical applications of polylactic acid/polyglycolic acid copolymers. Biomaterials199617, 93–102
86.
WeirN. A.BuchananF. J.OrrJ. F.Degradation of poly-L-lactide. Part 1: in vitro and in vivo physiological temperature degradation. J. Engng Med.2004218, 307–319
87.
RamayH. R.ZhangM.Biphasic calcium phosphate nanocomposite porous scaffolds for load-bearing bone tissue engineering. Biomaterials200421, 171–180
88.
BeckerJ.KirschA.SchwarzF.Bone apposition to titanium implants biocoated with recombinant human bone morphogenetic protein-2 (rhBMP-2). A pilot study in dogs. Clin. Oral Invest.200610, 217–224
89.
SchliephakeH.ArefA.ScharnweberD.Effect of immobilized bone morphogenic protein 2 coating of titanium implants on peri-implant bone formation. Clin. Oral Implants Res.200516, 563–569
90.
GovenderS.CsimmaC.GenantH. K.Recombinant human bone morphogenetic protein-2 for treatment of open tibial fractures: A prospective, controlled, randomized study of four hundred and fifty patients. J. Bone Joint Surg. Am.200284A, 2123–2134
91.
GiannoudisP. V.TzioupisC.Clinical applications of BMP-7: The UK perspective. Injury200536, (S3), S47–S50
92.
FriedlaendeG. E.PerryC. R.ColeJ. D.CookS. D.CiernyG.MuschlerG. F.ZychG. A.CalhounJ. H.LaForteA. J.YinS.Osteogenic protein-1 (bone morphogenetic protein-7) in the treatment of tibial nonunions. J. Bone Joint Surg. Am.200183A, (S1(Pt 2)), S151–S158
93.
TermaatM. F.den BoerF. C.BakkerF. C.Bone morphogenetic proteins: Development and clinical efficacy in the treatment of fractures and bone defects. J Bone Joint Surg. Am.200587, 1367–1378
94.
SchmidmaierG.SchwabeP.WildemannB.Use of bone morphogenetic proteins for treatment of non-unions and future perspectives. Injury200738, (S4), S35–S41
VaccaroA. R.AndersonD. G.PatelT.Comparison of OP-1 putty (rhBMP-7) to iliac crest autograft for posterolateral lumbar arthrodesis. A minimum 2-year follow-up pilot study. Spine200530, (24), 2709–2716
97.
GlassmanS. D.CarreonL.DjurasovicM.Posterolateral lumbar spine fusion with INFUSE bone graft. Spine J.20077, (1), 44–49
98.
GlassmanS. D.CarreonL. Y.DjurasovicM.RhBMP-2 versus iliac crest bone graft for lumbar spine fusion: A randomized, controlled trial in patients over sixty years of age. Spine200833, (26), 2843–2849
99.
SinghK.SmuckerJ. D.GillS.Use of recombinant human bone morphogenetic protein-2 as an adjunct in posterolateral lumbar spine fusion: A prospective CT-scan analysis at one and two years. J. Spinal Disord. Tech.200619, (6), 416–423
100.
WongD. A.KumarA.JatanaS.Neurologic impairment from ectopic bone in the lumbar canal: A potential complication of off-label PLIF/TLIF use of bone morphogenetic protein-2 (BMP-2). Spine J.20088, (6), 1011–1018
101.
CahillK. S.ChiJ. H.DayA.Prevalence, complications, and hospital charges associated with use of bone-morphogenetic proteins in spinal fusion procedures. J. Am. Med. Assoc.2009302, (1), 58–66
BuckwalterJ. A.GlimcherM. J.CooperR. R.Bone biology. J. Bone Joint Surg. Am.199577, 1276–1289
104.
HulbertS. F.YoungF. A.MathewsR. S.Potential of ceramic materials as permanently implantable skeletal prostheses. J. Biomed. Mater. Res.19704, 433–456
105.
KasperkC.EwersR.SimonsB.Algae-derived (phycogene) hydroxylapatite. A comparative histological study. Int. J. Oral Maxillofac. Surg.198817, 319–324
106.
RoudierM.BouchonC.RouvillainJ. L.The resorption of bone-implanted corals varies with porosity but also with the host-reaction. J. Biomed. Mater. Res.199529, (8), 909–915
107.
ThalgottJ. S.KlezlZ.TimlinM.Anterior lumbar interbody fusion with processed sea coral (coralline hydroxyapatite) as part of a circumferential fusion. Spine200227, (24), E518–E527
108.
WhiteE.WeberJ. N.RoyD. M.Replamineform porous biomaterials for hard tissue implant applications. J. Biomed. Mater. Res. Symp.19756, 23–27
109.
GuilleminG.MeunierA.DallantP.Comparison of coral and bone apposition with two natural corals of different porosities. J. Biomed. Mater. Res.198923, 765–779
110.
AraizaM. A.Gomez-MoralesJ.Rodriguez-ClementeR.Conversion of the echinoderm Mellita eduardobarrosoi calcite skeleton into porous hydroxyapatite by treatment with phosphated boiling solutions. J. Mater. Synth. Proc.19997, (4), 211–219
111.
WalshD.MannS.Fabrication of hollow porous shells of calcium carbonate from self-organizing media. Nature1995377, 320–323
112.
WongM. E. J.SchenkR.HunzikerE.Effect of surface topology on the osseointegration of implant materials in trabecular bone. J. Biomed. Mater. Res.199529, 1567–1575
113.
ParkJ. Y.GemmellC. H.DaviesJ. E.Platelet interactions with titanium: Modulation of platelet activity by surface topography. Biomaterials200122, 2671–2682
114.
RicciJ. L.GrewJ. C.AlexanderH.Growth of rat fibroblast and bone marrow cell colonies on microgrooved surfaces. J. Biomed. Mater. Res.200785, (2), 313–326
115.
BuserD.SchenkR. K.SteinemannS.Influence of surface characteristics on bone integration of titanium implants. A histomorphometric study in miniature pigs. J. Biomed. Mater. Res.199125, 889–902
116.
ShalabiM. M.GortemakerA.van't HofM. A.Implant surface roughness and bone healing: A systematic review. J. Dent. Res.200685, 496–500
117.
PriceR. L.GutweinL. G.KaledinL.Osteoblast function on nanophase alumina materials: Influence of chemistry, phase, and topography. J. Biomed. Mater. Res. A200367, 1284–1293
118.
WebsterT. J.ErgunC.DoremusR. H.Specific proteins mediate enhanced osteoblast adhesion on nanophase ceramics. J. Biomed. Mater. Res.200051, 475–483
119.
McManusA. J.DoremusR. H.SiegelR. W.Evaluation of cytocompatibility and bending modulus of nanoceramic/polymer composites. J. Biomed. Mater. Res. A200572, 98–106
120.
ZhaoG.ZingerO.SchwartzZ.Osteoblast-like cells are sensitive to sub-micron scale surface structure. Clin. Oral Implants Res.200617, 258–268
121.
DalbyM. J.RiehleM. O.JohnstoneH.AffrossmanS.CurtisA. S.Investigating the limits of filopodial sensing: A brief report using SEM to image the interaction between 10 nm high nano-topography and fibroblast filopodia. Cell. Biol. Int.200428, (3), 229–236
122.
DalbyM. J.di SilvioL.DaviesG. W.BonfieldW.Surface topography and HA filler volume effect on primary human osteoblasts in vitro. J. Mater. Sci., Mater. Med.200012, 805–810
123.
DalbyM. J.GadegaardN.RiehleM. O.WilkinsonC. D.CurtisA. S.Investigating filopodia sensing using arrays of defined nano-pits down to 35 nm diameter in size. Int. J. Biochem. Cell Biol.200436, (10), 2005–2115
124.
DalbyM. J.GadegaardN.TareR.The control of human mesenchymal cell differentiation using nanoscale symmetry and disorder. Nat. Mater.20076, 997–1003
125.
ColonG.WardB. C.WebsterT. J.Increased osteoblast and decreased staphylococcus epidermis functions on nanophase ZnO and TiO2. J. Biomed. Mater. Res. A200678, 595–604
126.
LiuH.SlamovichE. B.WebsterT. J.Increased osteoblast functions among nanophase titania/poly (lactide-co-glycolide) composites of the highest nanometer surface roughness. J. Biomed. Mater. Res. A200678, 798–807
127.
BonfieldW.TannerE.Mater. World19975, 18–20
128.
LemonsJ. E.NiemannK. M.WeissA. B.Biocompatibility studies on surgical-grade titanium-, cobalt-, and iron-base alloys. J. Biomed. Mater. Res.197610, 549–553
129.
SuskaF.GretzerC.EspositoM.In vivo cytokine secretion and NF-kappaB activation around titanium and copper implants. Biomaterials200526, 519–527
130.
HaynesD. R.RogersS. D.HayS.The differences in toxicity and release of bone-resorbing mediators by titanium and cobalt-chromium-alloy wear particles. J. Bone Joint Surg. Am.199375, 825–834
131.
FaleiroC.GodinhoI.ReusU.Cobalt-chromium-molybdenum but not titanium-6aluminium-4vandium alloy discs inhibit human T cell activation in vitro. Biometals19969, 321–326
132.
PypenC. M.DesseinK.HelsenJ. A.Comparison of the cytotoxicity of molybdenum as powder and as alloying element in a niobium-molybdenum alloy. J. Mater. Sci., Mater. Med.19989, 761–765
133.
ShanbagA. S.JacobsJ. J.BlackJ.Macrophage/particle interactions: Effect of size, composition and surface area. J. Biomed. Mater. Res.199428, 81–90
134.
ShanbagA. S.JacobsJ. J.BlackJ.Human monocyte response to particulate biomaterials generated in vivo and in vitro. J. Orthop. Res.199513, 792–801
135.
RajaratnamS. S.JackC.TavakkolizadehA.Long-term results of a hydroxyapatite-coated femoral component in total hip replacement: A 15- to 21-year follow-up study. J. Bone Joint Surg. Br.200890B, 27–30
136.
BobynJ. D.StackpoolG.HackingS. A.Bone ingrowth characteristics and interface mechanics of a new porous tantalum biomaterial. J. Bone Joint Surg. Br.199981, (5, 907–914
137.
AbronA.HopfenpergerM.ThompsonJ.Evaluation of a predictive model for implant surface topography effects on early osseointegration in the rat tibia model. J. Prosthet. Dent.200185, 40–46
138.
CooperL. F.ZhouY.TkebeJ.Fluoride modification effects on osteoblast behavior and bone formation at TiO2 grit blasted CpTitanium endosseous implants. Biomaterials200627, 926–936
139.
BerglundhT.AbrahammsonI.AlbouyJ. P.Bone healing at implants with a fluoride-modified surface: An expermental study in dogs. Clin. Oral Implants Res.200718, 147–152
140.
AbrahamssonI.AlbouyJ. P.BerglundhT.Healing at fluoride-modified implants placed in wide marginal defects: An experimental study in dogs. Clin. Oral Implants Res.200819, 153–159
141.
MendesV. C.MoineddenR.DaviesJ. E.Discrete calcium phosphate nanocrystalline deposition enhances osteoconduction on titanium-based implant surfaces. J. Biomed. Mater. Res. A200990, (2), 577–585
142.
MendesV. C.MoineddenR.DaviesJ. E.The effect of discrete calcium phosphate nanocrystals on bone-bonding to titanium surfaces. Biomaterials200728, 4748–4755
143.
SetzerB.BächleM.MetzgerM. C.The gene-expression and phenotypic response of hFOB 1.19 osteoblasts to surface-modified titanium and zirconia. Biomaterials200930, (6), 979–990
144.
KnutsenG.DrogsetJ. O.EngebretsenL.GrøntvedtT.IsaksenV.LudvigsenT. C.RobertsS.SolheimE.StrandT.JohansenO.A randomized trial comparing autologous chondrocyte implantation with microfracture. Findings at five years. J. Bone Joint Surg. Am.200789, (10), 2105–2112
145.
MoskowitzJ. S.BlaisseM. R.SamuelR. E.HsuH. P.HarrisM. B.MartinS. D.LeeJ. C.SpectorM.HammondP. T.The effectiveness of the controlled release of gentamicin from polyelectrolyte multilayers in the treatment of Staphylococcus aureus infection in a rabbit bone model. Biomaterials201031, (23), 6019–6030
146.
ChenW. J.ZhangF.MustainW. C.TucciM.HuE. C.LineaweaverW. C.Prefabrication of vascularised bone flap by demineralized bone matrix. J. Craniofac. Surg.200718, (1), 43–48
